Mark A McCoy

Title: Mark A McCoy: Innovator in Kinase Inhibitors

Introduction

Mark A McCoy is a notable inventor based in Randolph, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 2 patents to his name, McCoy's work has the potential to impact the treatment of various diseases.

Latest Patents

McCoy's latest patents include innovative compounds that serve as kinase inhibitors. One of his key inventions is a compound of the formula 1.0, which is disclosed along with its pharmaceutically acceptable salts. This compound is designed to treat protein kinase mediated diseases, including cancer. The methods outlined in his patents also encompass combination therapies, where the compound is administered alongside at least one additional pharmaceutically active ingredient. Furthermore, the compounds he has developed are useful in treating a range of conditions such as immunodeficiencies, cardiovascular diseases, and neurodegeneration.

Career Highlights

Mark A McCoy is currently associated with Schering Corporation, where he continues to advance his research in the pharmaceutical field. His work is characterized by a commitment to developing effective treatments for serious health conditions.

Collaborations

Some of McCoy's notable coworkers include Tin-Yau Chan and Brian Alexander McKittrick. Their collaborative efforts contribute to the innovative research environment at Schering Corporation.

Conclusion

Mark A McCoy's contributions to the field of kinase inhibitors highlight his role as a significant inventor in the pharmaceutical industry. His innovative approaches to treating complex diseases demonstrate the importance of continued research and development in this vital area.